SCHEMBL376530

SCHEMBL376530

CCOC(=O)c1ccc(N2CCC(Cc3ccccc3F)(OC)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
TSHR P16473 2/20 0.44
MAPT P10636 6/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 3/20 0.42
POLB P06746 1/20 0.42
BCL2L1 Q07817 2/20 0.42
BCL2 P10415 1/20 0.42
TRPV4 Q9HBA0 1/20 0.42
TP53 P04637 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CETP P11597 1/20 0.41
HPGD P15428 3/20 0.41
HTT P42858 2/20 0.41
METAP1 P53582 1/20 0.40
CASP1 P29466 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL376254 0.87 ALDH1A1 (0.45) ALDH1A1TSHRMAPTLMNAMEN1
SCHEMBL2965712 0.87 BCL2L1 (0.46) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL376911 0.86 PARP14 (0.45) ALDH1A1MAPTMEN1KMT2ABCL2L1
SCHEMBL386110 0.83 F2 (0.47) MAPTMEN1KMT2ABCL2L1BCL2
SCHEMBL13503798 0.79 ALDH1A1 (0.42) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL1742831 0.79 MAPT (0.43) ALDH1A1TSHRMAPTLMNAMEN1
SCHEMBL376529 0.78 BCL2L1 (0.40) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL6134196 0.78 HTT (0.46) ALDH1A1TSHRMAPTLMNAMEN1
SCHEMBL2962385 0.78 KMT2A (0.38) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL376891 0.77 KDM4E (0.45) MAPTMEN1KMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765778-B1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LAB (US) 2012-01-25 EP disclosed
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES 2010-02-11 US disclosed
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES 2010-02-11 US disclosed
US-7585858-B2 N-sulfonylcarboximidamide apoptosis promoters ABBOTT LABORATORIES (US) 2009-09-08 US disclosed
US-20050272744-A1 N-sulfonylcarboximidamide apoptosis promoters ABBVIE INC. 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS BAX, BCL2, BAD ALDH1A1 2354/4885TSHR 4115/4885MAPT 4433/4885
US-20050272744-A1 N-sulfonylcarboximidamide apoptosis promoters BAX, BCL2, BAD ALDH1A1 2354/4885TSHR 4115/4885MAPT 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.